International Registry on Cardioversion of Atrial Fibrillation
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Atrial Fibrillation
- Sponsor
- Merck Sharp & Dohme LLC
- Enrollment
- 4658
- Primary Endpoint
- Clinical Type of Atrial Fibrillation at Baseline (Admission)
- Status
- Completed
- Last Updated
- last year
Overview
Brief Summary
This study will create a prospective registry of consecutive patients with Atrial Fibrillation (Afib) considered for cardioversion treatment to document up-to-date practice of in-hospital treatment, with a focus on the characterization of type of Afib, as well as on treatments applied (drugs, devices, interventions and their combinations), and associated complications within 60 days after enrollment.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Participant with documented atrial fibrillation (confirmed by electrocardiogram) in the hospital setting at the time of enrollment
- •Planned cardioversion (of atrial fibrillation)
Exclusion Criteria
- •Already enrolled in this or any other clinical trial
- •Atrial flutter
Outcomes
Primary Outcomes
Clinical Type of Atrial Fibrillation at Baseline (Admission)
Time Frame: Baseline (time of admission)
Percentage of Participants Who Had a Successful Electrical or Pharmacological Cardioversion
Time Frame: At time of treatment (up to 1 day from admission)
Pharmacological cardioversion was considered successful if sinus rhythm or atrial rhythm was obtained within 24 hours after its initiation. Electrical cardioversion was considered successful if sinus rhythm was obtained and maintained for at least 10 minutes after the last shock was administered.
Co-Morbidity in Participants Presenting With Atrial Fibrillation at Baseline (Admission)
Time Frame: Baseline (time of admission)
Complications Experienced by Participants Who Underwent a Cardioversion for Treatment of Atrial Fibrillation
Time Frame: up to 60 days from day of treatment (cardioversion)
Treatments Utilized for Participants for Atrial Fibrillation
Time Frame: At time of Treatment (up to 1 day from admission)
Cardiovascular Disease History of Participants Presenting With Atrial Fibrillation at Baseline (Admission)
Time Frame: Baseline (time of admission)